NIQS Tech is developing a non-invasive glucose monitoring sensor that utilizes novel optical interactions to provide continuous and accurate glucose level measurements without the need for needles or blood samples. This technology addresses the challenges of traditional glucose monitoring methods, making diabetes management simpler and more accessible for patients.
Funding
$390K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for glucose monitoring often involve invasive procedures, such as needles or drawing blood, which can deter individuals from regularly measuring their glucose levels. This can lead to ineffective diabetes management and increase the likelihood of complications.
Solution
NIQS Tech is developing a non-invasive glucose monitoring sensor that utilizes a novel optical interaction to provide continuous and accurate glucose level measurements without the need for needles or blood samples. The sensor aims to simplify regular measurements and encourage effective diabetes management practices. By eliminating the need for invasive procedures, NIQS Tech's solution seeks to empower individuals with diabetes to proactively manage their condition, reduce the risk of complications, and improve their overall quality of life. The technology focuses on providing actionable insights into glucose levels, making it easier for users to maintain healthy habits and prevent negative impacts on their health.
Target Audience
The primary target audience includes individuals with diabetes who require regular glucose monitoring, as well as healthcare providers seeking accessible and user-friendly solutions for diabetes management.
Features
- Non-invasive glucose monitoring using novel optical interaction technology
- Continuous and accurate glucose level measurements
- Needle-free and blood-free operation